UNIV OF DEBRECEN has a total of 12 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), Australia and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are AXEN BIO GROUP SP Z O O, KINDEX PHARMACEUTICALS INC and TEVA PHARM FINE CHEMICALS SRL.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | Australia | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Foods and drinks | |
#4 | Measurement | |
#5 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Acyclic or carbocyclic compounds | |
#3 | Organic chemistry methods | |
#4 | Special foods | |
#5 | Analysing materials | |
#6 | Foods | |
#7 | Peptides | |
#8 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | De Lera Angel R | 8 |
#2 | Krezel Wojciech | 8 |
#3 | Rühl Ralph | 6 |
#4 | Bagossi Peter | 2 |
#5 | Fesus Laszlo | 2 |
#6 | Csosz Eva | 2 |
#7 | Simon-Vecsei Zsofia | 2 |
#8 | Kiraly Robert | 2 |
#9 | Maki Markku | 2 |
#10 | Ruhl Ralph | 2 |
Publication | Filing date | Title |
---|---|---|
US2019054056A1 | Precursor compounds for providing retinoids of the vatamin a5 pathway and uses thereof | |
US2018170867A1 | Stereoselective synthesis of 9-cis.13,14-dihydroretinoic acid and its ethyl esters | |
EP2834268A1 | Modified peptide toxins |